Literature DB >> 8464240

LIF mRNA expression is transcriptionally regulated in murine bone marrow stromal cells.

H G Derigs1, H S Boswell.   

Abstract

Recent evidence has established an important role for leukemia inhibitory factor (LIF) as hematopoietically active cytokine. The present study utilized two different murine bone marrow stromal cell lines, +/+-1.LDA11 and MBA-13, to define regulatory mechanisms of LIF messenger RNA (mRNA) induction. LIF mRNA was not detected in uninduced stromal cells under serum-free conditions. Incubation with interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha) or the cAMP analogue 8-bromoadenosine 3':5'-monophosphate (8BrcAMP) resulted in weakly induced LIF mRNA. Coincubation of combinations of the stimuli increased LIF mRNA expression additively. LIF mRNA stability, even after stimulation, was low with a half-life of about 30 min, suggesting a functional role for known AU-rich motifs in the 3' untranslated LIF mRNA region in mediating this instability. This possibility was further supported by the ability of cycloheximide to increase mRNA levels without affecting transcription. Transcriptional activation was found to be the main mechanism leading to LIF mRNA expression by IL-1, by TNF-alpha, and by 8BrcAMP. These stimuli appeared to act additively in this regard, suggesting involvement of distinct transcription factors. Induction of transcription was detected 45 min post-stimulation and showed peak levels at 90 min. Kinetics of LIF transcriptional activation showed similarity with the kinetics of the transcription factors, jun-B and c-fos, suggesting a possible role for these proteins or other early response genes in events leading to LIF expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464240

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  4 in total

1.  Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling.

Authors:  Matthew P Keasey; Cuihong Jia; Lylyan F Pimentel; Richard R Sante; Chiharu Lovins; Theo Hagg
Journal:  J Cell Sci       Date:  2018-02-02       Impact factor: 5.285

2.  Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis.

Authors:  Ming Ruan; Larry Pederson; Elizabeth W Bradley; Ana-Maria Bamberger; Merry Jo Oursler
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

3.  Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.

Authors:  Rachelle W Johnson; Elizabeth C Finger; Monica M Olcina; Marta Vilalta; Todd Aguilera; Yu Miao; Alyssa R Merkel; Joshua R Johnson; Julie A Sterling; Joy Y Wu; Amato J Giaccia
Journal:  Nat Cell Biol       Date:  2016-09-19       Impact factor: 28.824

4.  cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro.

Authors:  G Bug; J Aman; C Huber; C Peschel; H G Derigs
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.